Feedback / Questions
GS-8824 - Gilead
GS-8824: Initiated P1 NAPISTAR-1-02 Study in 2L-3L PSOC Patients
(Gilead)
-
Aug 8, 2026 -
"Registrational Trial Initiation Expected in 2027"
New trial • Platinum sensitive • Trial status
•
Ovarian Cancer
https://s29.q4cdn.com/585078350/files/doc_financials/2026/q2/GILD-Q226-Earnings-Presentation-4-August-2026.pdf
Aug 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious